0.316
전일 마감가:
$0.283
열려 있는:
$0.309
하루 거래량:
2.69M
Relative Volume:
3.00
시가총액:
$11.10M
수익:
$2.63M
순이익/손실:
$-19.13M
주가수익비율:
-0.8815
EPS:
-0.3585
순현금흐름:
$-5.27M
1주 성능:
-28.67%
1개월 성능:
-12.73%
6개월 성능:
-36.29%
1년 성능:
-39.36%
Osr Health Inc Stock (OSRH) Company Profile
명칭
Osr Health Inc
전화
425-635-7700
주소
10900 NE 4TH STREET, SUITE 2300, BELLEVUE
Compare OSRH vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
OSRH
Osr Health Inc
|
0.316 | 10.15M | 2.63M | -19.13M | -5.27M | -0.3585 |
|
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
|
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
|
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Osr Health Inc 주식(OSRH)의 최신 뉴스
OSR Health, Inc. Q2 2026: Revenue $316K, Net loss $(849K), EPS $(0.02) — 10-Q Summary - TradingView
OSR Health (OSRH) cuts losses but faces sharp revenue drop and tight cash - Stock Titan
OSR Health Issues Clarification Regarding Prior Nasdaq Communication and Shareholder Loyalty CVR Program - ACCESS Newswire
OSR Health faces Nasdaq delisting deadline, cites licensing talks - Investing.com
OSR Health CEO Reaffirms Confidence and Highlights Subsidiary Business Development - New Castle News
OSR Health clarifies Nasdaq has not approved shareholder loyalty CVR program - Bitget
Form 8K OSR Holdings Inc For: 10 August By Investing.com - Investing.com Nigeria
OSR Health re-elects board and approves key proposals at annual meeting - Investing.com
OSR Health, Inc. (OSRHW) Stock Price, News, Quote & History - Yahoo! Finance Canada
Form 8K OSR Holdings Inc For: 7 August By Investing.com - Investing.com Nigeria
OSR Holdings Clarifies Nasdaq Stance on CVR Program - TipRanks
OSR Health clarifies Nasdaq did not endorse CVR program; record date remains Aug 14 - TradingView
OSR (OSRH) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - marketbeat.com
OSR Health subsidiary completes glioblastoma vaccine analysis By Investing.com - Investing.com Australia
OSR Health subsidiary completes glioblastoma vaccine analysis - Investing.com
Vaximm AG, an OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its VEGFR-2-Targeted Cancer Vaccine Platform - New Castle News
Vaximm Announces VXM01 Glioblastoma Data Publication Plans - ACCESS Newswire
OSR Health says Nasdaq won’t apply price adjustment for loyalty CVR distribution - TradingView
OSR Health Secures Nasdaq Communication: Loyalty CVR Program Will Not Trigger a Price Adjustment - The Joplin Globe
OSR Holdings Inc (OSRH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OSR Holdings Inc (OSRH) Institutional Confidence - TradingKey
OSR Holdings Inc (OSRH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OSR Holdings Inc (OSRH) Balance Sheet - TradingKey
OSR Health, Inc. Revenue Breakdown – NASDAQ:OSRH - TradingView
OSRH|OSR Holdings Inc|Price:0.423|Chg%:-0.027 - TradingKey
OSR Holdings Inc (OSRH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OSRH|OSR Holdings Inc|Price:0.295|Chg%:+0.012 - tradingkey.com
OSR Holdings Inc (OSRH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OSR HEALTH INC (OSRH) Stock Chart - ChartMill
OSR Health Inc (BLACR:UR): Stock Price, Quote and News - BNN Bloomberg
OSR Health, A Message From the CEO - Chronicle-Tribune
Form DEF 14A OSR Holdings Inc For: 16 July By Investing.com - Investing.com Canada
OSR Health Inc (BLACU:UR): Stock Price, Quote and News - BNN Bloomberg
Share boost, loyalty program plan on ballot at OSR Health, Inc. (NASDAQ: OSRH) - Stock Titan
OSR Health CEO Letter on Shareholder Loyalty CVR Program - ACCESS Newswire
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Form PRE 14A OSR Holdings Inc For: 6 July By Investing.com - Investing.com Canada
OSR Health (NASDAQ: OSRH) asks shareholders to approve a 150M share increase - Stock Titan
Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target - ACCESS Newswire
OSRHOSR Health Inc Volatility & Greeks - Finviz
OSR Holdings Inc. (OSRH) Gains 2.26% as Shares Approach $0.34 ResistanceLow Volume Node - dars.gov.et
CORRECTION FROM SOURCE: Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target - ACCESS Newswire
Enterprise value to EBIT forward of OSR Health, Inc. – NASDAQ:OSRH - TradingView
OSRH Q4 2025 Earnings: EPS Falls Short of Estimates, Shares DeclineEarnings Surprise Report - dars.gov.et
Enterprise value to EBIT forward of OSR Health, Inc. – NASDAQ:OSRHW - TradingView
Osr Health Inc (OSRH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):